These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

930 related items for PubMed ID: 9680502

  • 1. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
    Borgeson DD, Stevens TL, Heublein DM, Matsuda Y, Burnett JC.
    Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
    [Abstract] [Full Text] [Related]

  • 2. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations.
    Hirose M, Furukawa Y, Kurogouchi F, Nakajima K, Miyashita Y, Chiba S.
    J Pharmacol Exp Ther; 1998 Jul; 286(1):70-6. PubMed ID: 9655843
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. B-type natriuretic peptide infusions in acute myocardial infarction.
    Hillock RJ, Frampton CM, Yandle TG, Troughton RW, Lainchbury JG, Richards AM.
    Heart; 2008 May; 94(5):617-22. PubMed ID: 17639095
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling.
    Zhang Q, Moalem J, Tse J, Scholz PM, Weiss HR.
    Eur J Pharmacol; 2005 Mar 14; 510(3):209-15. PubMed ID: 15763244
    [Abstract] [Full Text] [Related]

  • 8. A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction.
    Stevens TL, Burnett JC, Kinoshita M, Matsuda Y, Redfield MM.
    J Clin Invest; 1995 Mar 14; 95(3):1101-8. PubMed ID: 7883958
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. I. Selective inhibition of the actions of natriuretic peptides in anesthetized rats.
    Sano T, Morishita Y, Matsuda Y, Yamada K.
    J Pharmacol Exp Ther; 1992 Feb 14; 260(2):825-31. PubMed ID: 1346647
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Natriuretic peptides in relation to the cardiac innervation and conduction system.
    Hansson M.
    Microsc Res Tech; 2002 Sep 01; 58(5):378-86. PubMed ID: 12226807
    [Abstract] [Full Text] [Related]

  • 12. Natriuretic peptides and their therapeutic potential.
    Cho Y, Somer BG, Amatya A.
    Heart Dis; 1999 Sep 01; 1(5):305-28. PubMed ID: 11720638
    [Abstract] [Full Text] [Related]

  • 13. Neurohumoral mechanism in the natriuretic action of intracerebroventricular administration of renin.
    Zavala L, Barbella Y, Israel A.
    J Renin Angiotensin Aldosterone Syst; 2004 Mar 01; 5(1):39-44. PubMed ID: 15136973
    [Abstract] [Full Text] [Related]

  • 14. Atrial natriuretic peptide (ANP) inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension.
    Leskinen H, Vuolteenaho O, Toth M, Ruskoaho H.
    Endocrinology; 1997 May 01; 138(5):1893-902. PubMed ID: 9112384
    [Abstract] [Full Text] [Related]

  • 15. Role of natriuretic peptides in cGMP production in fetal cardiac bypass.
    Heeb EA, Baker RS, Lam C, Basu M, Lubbers W, Duffy JY, Eghtesady P.
    Ann Thorac Surg; 2009 Mar 01; 87(3):841-7. PubMed ID: 19231402
    [Abstract] [Full Text] [Related]

  • 16. Acute cardiac volume load-related changes in plasma atrial natriuretic peptide and N-terminal pro-B-type natriuretic peptide concentrations in healthy dogs.
    Hori Y, Sano N, Kanai K, Hoshi F, Itoh N, Higuchi S.
    Vet J; 2010 Sep 01; 185(3):317-21. PubMed ID: 19709913
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A, Boerrigter G, Costello-Boerrigter LC, Schirger JA, Tsuruda T, Heublein DM, Chen HH, Malatino LS, Burnett JC.
    Circulation; 2004 Apr 06; 109(13):1680-5. PubMed ID: 15023890
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.